Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Recovering Zimbabwe Offers Growth Opportunities for Pharmaceutical Companies, Says Frost & SullivanRecovery from a decade-long economic contraction has been the main factor behind the growth experienced in Zimbabwe’s pharmaceutical sector in the last two years.
By: Frost & Sullivan New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com) “A recovering economy, which has brought price stability and rising incomes, is behind the increase in expenditure,” Zimbabwe is in the midst of economic recovery, and rising incomes are already driving the demand for quality healthcare products. Economic growth, coupled with the greater availability of affordable generic drugs, will spur the uptake of pharmaceuticals. Over the course of Zimbabwe’s economic slump, the country’s once vibrant pharmaceutical industry had shrunk by over 50 per cent, and by 2008, capacity utilisation stood at a mere 20 per cent. Although the economy has since recovered, significant challenges remain for local manufacturers, mainly in the form of lack of capital. “The country has struggled to attract capital and access loan facilities from international lenders due to the government’s unfavourable credit record,” explains Zingoni. “Limited access to capital has therefore inhibited investment in new plants and equipment, and thus production levels have remained low. Without an optimally operating manufacturing industry, shortages of affordable medicines will remain unresolved.” The direction of long-term policy in Zimbabwe and many countries in the sub-Saharan Africa is moving towards promoting local manufacturing of generic drugs. In that regard, foreign investors have an important role to play in the country’s pharmaceutical sector. As the economy of Zimbabwe has now stabilised, the opportunity for international investors lies in the provision of business capital, with possible guarantees negotiated with the government. “Injection of capital into local firms would enable upgrade of facilities, and thus unlock new markets, most notably donor-financed tenders and regional export markets,” concludes Zingoni. “A pre-requisite for suppliers wishing to tap into these markets is meeting WHO quality certification, standards which most local manufacturers currently do not meet.” Healthcare Overview in Zimbabwe is part of the Medical Devices Growth Partnership Services programme, which also includes research in the following markets: Strategic Analysis of Medical Imaging Devices in Kenya, Strategic Analysis of Medical Imaging devices In Ghana and Nigeria, Strategic Analysis of the Healthcare Industry in Kenya, Strategic Analysis of the Healthcare Industry in Tanzania and The Medical Insurance Markets in sub-Sahara Africa. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. If you are interested in more information about this study, please send an e-mail to Christie Cronje, Corporate Communications, at christie.cronje@ About Frost & Sullivan Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com Healthcare Overview in Zimbabwe M5DC Contact: Christie Cronje Corporate Communications – Africa P: +27 18 464 2402 E: christie.cronje@ http://www.frost.com # # # Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's research and consulting services empower clients to generate, evaluate, and implement effective growth strategies. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|